IOL Chemicals receives EDQM certificate for Pantoprazole Sodium Sesquihydrate Process-III

IOL Chemicals receives EDQM certificate for Pantoprazole Sodium Sesquihydrate Process-III

By: IPP Bureau

Last updated : October 16, 2025 10:26 am



Pantoprazole sodium is a proton pump inhibitor reduces stomach acid


IOL Chemicals and Pharmaceuticals Ltd has received a Certificate of Suitability for company's API product "antoprazole Sodium Sesquihydrate Process-III from European Directorate for the Quality of Medicines & Health Care (EDQM).

Pantoprazole sodium is a proton pump inhibitor (PPI) that reduces stomach acid and is used to treat conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome.

IOL Chemicals and Pharmaceuticals Ltd European Directorate for the Quality of Medicines & Health Care

First Published : October 16, 2025 12:00 am